Neurology

  • FDA approves safinamide to treat Parkinson’s disease

    on March 22nd, 2017
    The U.S. Food and Drug Administration approved safinamide tablets on March 21 as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes. Newron Pharmaceuticals will market safinamide under the brand name Xadago. Par[...]
  • People often think functional neurological symptoms are feigned

    on March 22nd, 2017
    FROM JOURNAL OF NEUROLOGY, NEUROSURGERY & PSYCHIATRY Clinicians, other caregivers, and even patients often think that functional neurological symptoms and movement disorders are feigned or somewhat amenable to the patient’s control, according to two separate survey studies published online in [...]
  • Get With the Guidelines propels stroke thrombolytic therapy

    on March 20th, 2017
    EXPERT ANALYSIS FROM THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Thrombolytic therapy for U.S. patients experiencing an acute ischemic stroke is no longer the poster child for proven, but neglected, therapies. Long bemoaned since its introduction in the mid-1990s as an e[...]
  • BNP flags high atrial fibrillation prevalence in ESUS stroke

    on March 20th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Following an embolic stroke of undetermined source, a patient’s serum level of brain natriuretic peptide may identify patients at high risk of having covert atrial fibrillation that warrants assessment by prolonged arrhyth[...]
  • Evolocumab doesn’t make patients dumb

    on March 20th, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Concerns about possible adverse cognitive effects from the new lipid-lowering drug evolocumab and from aggressive lowering of LDL cholesterol were largely put to rest with results from a nearly 2,000-patient study showing that a median 20 months of t[...]
  • On vacation, my patients go with me

    on March 14th, 2017
    I’m in the process of planning our family vacations for the summer. I do something different from most when on the road: I take my patients with me. Well, obviously not physically, but I do cover everything, no matter where I am. Yes, it takes time. In a ritual my family is used to, two […][...]
  • Seven shortcuts help with diagnosis of CNS vasculitis

    on March 14th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – A lumbar puncture is indispensable when entertaining the diagnosis of primary angiitis of the CNS, Leonard H. Calabrese, DO, declared at the Winter Rheumatology Symposium sponsored by the American Col[...]
  • Mobile stroke units becoming more common despite cost effectiveness questions

    on March 14th, 2017
    EXPERT ANALYSIS FROM THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Mobile stroke units – specially equipped ambulances that bring a diagnostic CT scanner and therapeutic thrombolysis directly to patients in the field – have begun to proliferate across the United States[...]
  • Ticagrelor improves platelet reactivity, but not clinical outcomes, in Chinese stroke patients

    on March 10th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – The combination of ticagrelor and aspirin reduced the incidence of high on-treatment platelet reactivity compared with clopidogrel plus aspirin in an interim analysis of a trial of patients with minor acute ischemic stroke o[...]
  • Expert provides deeper insight into tocilizumab for giant cell arteritis

    on March 8th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – The sustained remission rate in patients with giant cell arteritis was three times better with subcutaneous tocilizumab than with long-term prednisone in the landmark GiACTA trial, John H. Stone, MD, [...]
  • Dysautonomia significantly affects daily activities in advanced Parkinson’s

    on March 7th, 2017
    FROM MOVEMENT DISORDERS Nearly half of advanced Parkinson’s disease patients who receive treatment with subthalamic deep brain stimulation or levodopa-carbidopa intestinal gel infusion are affected by dysautonomia that has significant impacts on their daily lives, according to findings from a cros[...]
  • Vagus nerve stimulation shows stroke recovery promise

    on March 7th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Stroke patients with arm weakness had a clinically significant boost in arm function after about 19 weeks on a rehabilitation program that combined vagus nerve stimulation with rehabilitation training sessions in a multicent[...]
  • Protocol speeds thrombectomy stroke patients from primary centers

    on March 6th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – A novel protocol designed to speed patients with large-vessel occlusion strokes in and out of primary stroke centers and on to centers where they can undergo definitive thrombectomy treatment produced significant improvement[...]
Back to top